357 Super Magnum
- Manufacturer
- King Richard Promotions dba DBI
- Effective date
- 2016-05-19
- Label type
- HUMAN OTC DRUG LABEL
- Version
- 3
- Source
- full-release
- Hydrated at
- 2026-05-31 22:46:07
Label at a glance#
Contacts and useful links#
Label contents#
Full prescribing information#
OTC - ACTIVE INGREDIENT SECTION
Active ingredient (in each tablet)
Caffeine 200mg
OTC - PURPOSE SECTION
Purpose: Alertness Aid
INDICATIONS & USAGE SECTION
Use: Helps restore mental alertness or wakefulness when experiencing fatigue or drowsiness.
WARNINGS SECTION
Warnings: The recommended dose of this product contains about as much caffeine as a cup of coffee. Limit the use of caffeine-containing medications, foods, or beverages while taking this product because too much caffeine may cause nervousness, irritability, sleeplessness, and, occasionally, rapid heartbeat.
For occasional use only.Not intended for use as a substitute for sleep. If fatigue or drowsiness persists or continues to recur, consult a doctor.
Do not give to children under 12 years of age.
OTC - PREGNANCY OR BREAST FEEDING SECTION
If pregnant or breastfeeding, ask a health professional before use.
OTC - KEEP OUT OF REACH OF CHILDREN SECTION
Keep out of the reach of children.
OVERDOSAGE SECTION
In case of overdose, get medical help or contact a Poison Control Center immediately.
DOSAGE & ADMINISTRATION SECTION
Directions: Adults and children 12 years of age or older: 1/2 to 1 tablet, not more often than every 3-4 hours.
Children under 12 years: do not use.
OTHER SAFETY INFORMATION
Other Information:
Each tablet contains: Calcium 48mg
Store at room temperature.
Avoid excess heat (greater than 100°F) or humidity.
INACTIVE INGREDIENT SECTION
Inactive ingredients: blue #1 lake, croscarmellose sodium*, dicalcium phosphate , magnesium silicate*, magnesium stearate, microcrystalline cellulose, polyvinylpyrrolidone, red #27 lake, silicon dioxide, stearic acid, sugar, and titanium dioxide*
*Contains one or more of these ingredients
OTC - QUESTIONS SECTION
Questions?
Call toll-free 1-800-428-2352 Monday through Friday, 8a.m. to 5p.m. EST.
PACKAGE LABEL.PRINCIPAL DISPLAY PANEL
PACKAGE LABEL.PRINCIPAL DISPLAY PANEL
PACKAGE LABEL.PRINCIPAL DISPLAY PANEL
PACKAGE LABEL.PRINCIPAL DISPLAY PANEL
DailyMed RxNorm Mappings#
DailyMed Pharmacologic Classes#
| Class | Version | Type | Effective |
|---|---|---|---|
| CAFFEINE Pharmacologic Class Indexing | 2 | Indexing - Pharmacologic Class | 20180813 |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 7dea7767-9f52-b60a-5435-33cb9cc28bae | Product name | 4 | 20250124 |
| 6338270f-96cb-0ecb-6fbb-0a9bc78001f4 | Product name | 7 | 20250116 |
| 0ca83774-3f79-b837-5d6f-c210102f3bc8 | Product name | 6 | 20250114 |
| 41b814f3-0166-1c53-c9ef-a0794c7daf9d | Product name | 3 | 20221110 |
| a590be26-846c-8659-a5a1-fb25907965dc | Product name | 2 | 20221110 |
| 2dc76302-91c0-4c35-ad78-99adfb049c4b | Product name | 1 | 20200603 |
| e6065d4b-5ae1-476f-a40e-f2851cbb5d2b | Product name | 2 | 20180221 |
| f212291f-05fe-9603-fc7e-bd73e38ce1e6 | Product name | 2 | 20161129 |
| 182f9ab4-4ab5-c449-200f-87ce2ce8e550 | Product name | 2 | 20151105 |
| 332e86c3-7875-ca6e-f934-2206d2b31996 | Product name | 1 | 20140508 |
| 56625fcc-aa34-9d30-d0e9-1c1beb37ea21 | Product name | 1 | 20140508 |
| 7dfac40f-a405-cd2e-7c06-3059ec0e1092 | Product name | 1 | 20140508 |
| 96c2be53-8e44-452d-56a2-d255b2f1af2d | Product name | 1 | 20140508 |
| bf8bd5f7-495f-4022-2780-7ded7ea7ea44 | Product name | 1 | 20140508 |
| d223c173-c39b-d764-47d4-d671d3088815 | Product name | 1 | 20140508 |
| e01133ad-4dcd-c7f3-454b-2ff569ee160a | Product name | 1 | 20140508 |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 70682-941-03 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-15a9-f424-e053-dadaa90a57ce | 357 Super Magnum |
| 70682-941-21 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-15a9-f424-e053-dadaa90a57ce | 357 Super Magnum |
| 70682-941-36 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-15a9-f424-e053-dadaa90a57ce | 357 Super Magnum |
| 70682-941-51 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-15a9-f424-e053-dadaa90a57ce | 357 Super Magnum |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 70682-941-03 | 357 Super Magnum | 3 in 1 PACKET | TABLET, MULTILAYER | 3 | 3 | |
| 70682-941-21 | 357 Super Magnum | 100 in 1 BOTTLE | TABLET, MULTILAYER | 100 | 3 | |
| 70682-941-36 | 357 Super Magnum | 36 in 1 BOTTLE | TABLET, MULTILAYER | 36 | 3 | |
| 70682-941-51 | 357 Super Magnum | 500 in 1 PACKAGE | TABLET, MULTILAYER | 500 | 3 |
DailyMed Dashboard NDC Coverage#
Products#
Every source-derived product name is available through these pages.
- 357 Super Magnum
- Caffeine 200mg
- CAFFEINE
- D&C RED NO. 27
- DIBASIC CALCIUM PHOSPHATE DIHYDRATE
- FD&C BLUE NO. 1
- MAGNESIUM STEARATE
- CELLULOSE, MICROCRYSTALLINE
- POVIDONE
- SILICON DIOXIDE
- STEARIC ACID
- SUCROSE
- CROSCARMELLOSE SODIUM
- MAGNESIUM SILICATE
- TITANIUM DIOXIDE
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 70682-941 | 70682-941-03, 70682-941-36, 70682-941-21, 70682-941-51 |
Ingredients#
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| CAFFEINE | 3G6A5W338E | ACTIB |
| D&C RED NO. 27 | 2LRS185U6K | IACT |
| DIBASIC CALCIUM PHOSPHATE DIHYDRATE | O7TSZ97GEP | IACT |
| FD&C BLUE NO. 1 | H3R47K3TBD | IACT |
| MAGNESIUM STEARATE | 70097M6I30 | IACT |
| CELLULOSE, MICROCRYSTALLINE | OP1R32D61U | IACT |
| POVIDONE | FZ989GH94E | IACT |
| SILICON DIOXIDE | ETJ7Z6XBU4 | IACT |
| STEARIC ACID | 4ELV7Z65AP | IACT |
| SUCROSE | C151H8M554 | IACT |
| CROSCARMELLOSE SODIUM | M28OL1HH48 | CNTM |
| MAGNESIUM SILICATE | 9B9691B2N9 | CNTM |
| TITANIUM DIOXIDE | 15FIX9V2JP | CNTM |
Source Document#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| a23d0e47-01c6-4bcc-90ef-2365d0fbfc11 | 1acbee4e-6f23-4d0e-ab08-696c7d4cbd22 | 2016-05-19 | Warnings | a23d0e47-01c6-4bcc-90ef-2365d0fbfc11 1acbee4e-6f23-4d0e-ab08-696c7d4cbd22 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.



